P C Trask

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions
    P C Trask
    Behavioral Medicine Program, Department of Internal Medicine, and Department of Psychiatry, University of Michigan, Ann Arbor 48108, USA
    J Clin Oncol 18:2316-26. 2000
  2. ncbi Course of distress and quality of life in testicular cancer patients before, during, and after chemotherapy: results of a pilot study
    Peter C Trask
    Behavioral Medicine Program, University of Michigan, MI 48108, USA
    Psychooncology 12:814-20. 2003
  3. ncbi Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life
    Peter C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor, Michigan 48108, USA
    Cancer 98:854-64. 2003
  4. ncbi Behavioral medicine: the challenge of integrating psychological and behavioral approaches into primary care
    Peter C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor 48108-0757, USA
    Eff Clin Pract 5:75-83. 2002
  5. ncbi Comparison of headache parameters using headache type and emotional status
    P C Trask
    Behavioral Medicine Program, University of Michigan, Suite L, 475 Market Place, Ann Arbor, MI 48197 0757, USA
    J Psychosom Res 51:529-36. 2001
  6. ncbi Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning
    P C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor, MI 48108 0757, USA
    Psychooncology 10:349-60. 2001
  7. ncbi Psychosocial characteristics of individuals with non-stage IV melanoma
    P C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor, MI 48108, USA
    J Clin Oncol 19:2844-50. 2001
  8. ncbi Assessment of psychological distress in prospective bone marrow transplant patients
    P C Trask
    Behavioral Medicine Program, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, MI 48108-0757, USA
    Bone Marrow Transplant 29:917-25. 2002
  9. ncbi Screening for psychologic distress in ambulatory cancer patients
    Paul B Jacobsen
    Psychosocial and Palliative Care Program, Moffitt Cancer Center, Tampa, Florida 33612, USA
    Cancer 103:1494-502. 2005
  10. ncbi The identification of empirically derived cancer patient subgroups using psychosocial variables
    Peter C Trask
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Brown Medical School, Coro Building, Suite 500, One Hoppin Street, Providence, RI 02903, USA
    J Psychosom Res 57:287-95. 2004

Detail Information

Publications18

  1. ncbi Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions
    P C Trask
    Behavioral Medicine Program, Department of Internal Medicine, and Department of Psychiatry, University of Michigan, Ann Arbor 48108, USA
    J Clin Oncol 18:2316-26. 2000
    ..In addition, limitations of the current literature are provided with suggestions for treating physicians and a discussion of possible future research directions...
  2. ncbi Course of distress and quality of life in testicular cancer patients before, during, and after chemotherapy: results of a pilot study
    Peter C Trask
    Behavioral Medicine Program, University of Michigan, MI 48108, USA
    Psychooncology 12:814-20. 2003
    ..Deleterious changes in emotional distress, quality of life, and symptom distress seen in other cancer populations were not apparent in our sample of testicular cancer patients...
  3. ncbi Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life
    Peter C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor, Michigan 48108, USA
    Cancer 98:854-64. 2003
    ..The current study was designed to determine the effect of a cognitive-behavioral intervention on distress and health-related quality of life (HRQOL) in patients with melanoma who had medium-to-high distress...
  4. ncbi Behavioral medicine: the challenge of integrating psychological and behavioral approaches into primary care
    Peter C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor 48108-0757, USA
    Eff Clin Pract 5:75-83. 2002
  5. ncbi Comparison of headache parameters using headache type and emotional status
    P C Trask
    Behavioral Medicine Program, University of Michigan, Suite L, 475 Market Place, Ann Arbor, MI 48197 0757, USA
    J Psychosom Res 51:529-36. 2001
    ..The current study was designed to determine whether differences in subject variables arose when comparing them by headache type vs. empirically derived emotional distress clusters...
  6. ncbi Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning
    P C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor, MI 48108 0757, USA
    Psychooncology 10:349-60. 2001
    ....
  7. ncbi Psychosocial characteristics of individuals with non-stage IV melanoma
    P C Trask
    Behavioral Medicine Program, University of Michigan, Ann Arbor, MI 48108, USA
    J Clin Oncol 19:2844-50. 2001
    ..Given that the 5-year survival rates for individuals with melanoma are determined primarily by the depth and extent of spread, distress that interferes with seeking treatment has the potential to be life-threatening...
  8. ncbi Assessment of psychological distress in prospective bone marrow transplant patients
    P C Trask
    Behavioral Medicine Program, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, MI 48108-0757, USA
    Bone Marrow Transplant 29:917-25. 2002
    ....
  9. ncbi Screening for psychologic distress in ambulatory cancer patients
    Paul B Jacobsen
    Psychosocial and Palliative Care Program, Moffitt Cancer Center, Tampa, Florida 33612, USA
    Cancer 103:1494-502. 2005
    ..For this study, the authors sought to determine whether the single-item Distress Thermometer (DT) compared favorably with longer measures currently used to screen for distress...
  10. ncbi The identification of empirically derived cancer patient subgroups using psychosocial variables
    Peter C Trask
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Brown Medical School, Coro Building, Suite 500, One Hoppin Street, Providence, RI 02903, USA
    J Psychosom Res 57:287-95. 2004
    ..To determine if there are subgroups of cancer patients who differ on coping, psychological, and quality of life (QOL) measures, and to determine if these subgroups have a different course of distress and health following a cancer diagnosis...
  11. ncbi The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: a randomized, prospective clinical trial
    Jeffrey S Orringer
    Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA
    J Am Acad Dermatol 53:224-9. 2005
    ..Secondarily, we sought to compare these effects with those of a traditional clinic visit...
  12. ncbi Quality of life and emotional distress in advanced prostate cancer survivors undergoing chemotherapy
    Peter C Trask
    Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Brown Medical School, Coro Building, Suite 500, One Hoppin St, Providence, RI 02903, USA
    Health Qual Life Outcomes 2:37. 2004
    ..As such, increased attention is needed to quality of life during phase I-III chemotherapy trials...
  13. ncbi Transitions of care and changes in distressing pain
    Peter C Trask
    Centers for Behavioral and Preventive Medicine, Brown University Medical School The Miriam Hospital, Providence, Rhode Island 02903, USA
    J Pain Symptom Manage 32:104-9. 2006
    ..Increased attention is needed not only on how to adequately manage pain and pain-related distress but also on how to improve pain reduction measures in transitions between health care settings at the end of life...
  14. ncbi Effect of personal cancer history and family cancer history on levels of psychological distress
    Carolyn Rabin
    The Miriam Hospital and Brown Medical School, Providence, RI, USA
    Soc Sci Med 64:411-6. 2007
    ..Results extend prior research by indicating that having a first-degree relative with cancer increases risk for distress, and having personal and family cancer histories may exert a synergistic effect on distress...
  15. ncbi The contribution of pain-related anxiety to disability from headache
    Justin M Nash
    Centers for Behavioral and Preventive Medicine, Brown Medical School The Miriam Hospital, Providence, Rhode Island, USA
    J Behav Med 29:61-7. 2006
    ..These findings suggest that pain-related anxiety may have a unique and important role in contributing to disability in headache sufferers...
  16. ncbi Validation of the FACT-BRM with interferon-alpha treated melanoma patients
    Amber G Paterson
    Kaplan and Kaplan Psychologists, Canada
    Qual Life Res 14:133-9. 2005
    ..The FACT-BRM demonstrated good psychometrics and sensitivity to change, and thus appears to be a good instrument for measuring QOL in patients receiving BRMs...
  17. ncbi Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon
    Peter C Trask
    Centers for Behavioral and Preventive Medicine, Coro Bldg, Suite 500, One Hoppin St, Providence, RI 02903, USA
    Psychooncology 13:526-36. 2004
    ..Few, if any, studies have been conducted with the express purpose of assessing the longitudinal course of depression, fatigue, and QOL before and during interferon therapy...
  18. ncbi Health-related quality of life during treatment for renal cell carcinoma: results from a phase II study of axitinib
    Peter C Trask
    Global Outcomes Research, Pfizer Inc, New London, CT 06320, USA
    Acta Oncol 47:843-51. 2008
    ..This study examined the HRQOL of patients with metastatic RCC treated with axitinib, a new targeted therapy that affects the vessels supplying blood to the tumor...